These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35779512)

  • 1. Design, synthesis and evaluation of alpha lipoic acid derivatives to treat multiple sclerosis-associated central neuropathic pain.
    Kong D; Saqer AA; Carpinelli de Jesus M; Khan N; Jones A; Blanchfield JT; Smith MT; Williams CM
    Bioorg Med Chem; 2022 Sep; 69():116889. PubMed ID: 35779512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing bioavailability of (R)-alpha-lipoic acid to boost antioxidant activity in the treatment of neuropathic pain.
    Maglione E; Marrese C; Migliaro E; Marcuccio F; Panico C; Salvati C; Citro G; Quercio M; Roncagliolo F; Torello C; Brufani M
    Acta Biomed; 2015 Dec; 86(3):226-33. PubMed ID: 26694149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights on the Use of α-Lipoic Acid for Therapeutic Purposes.
    Salehi B; Berkay Yılmaz Y; Antika G; Boyunegmez Tumer T; Fawzi Mahomoodally M; Lobine D; Akram M; Riaz M; Capanoglu E; Sharopov F; Martins N; Cho WC; Sharifi-Rad J
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31405030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic Pain.
    Rais R; Vávra J; Tichý T; Dash RP; Gadiano AJ; Tenora L; Monincová L; Bařinka C; Alt J; Zimmermann SC; Slusher CE; Wu Y; Wozniak K; Majer P; Tsukamoto T; Slusher BS
    J Med Chem; 2017 Sep; 60(18):7799-7809. PubMed ID: 28759215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
    Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
    Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
    Khan N; Woodruff TM; Smith MT
    Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
    Cao F; Gao Y; Wang M; Fang L; Ping Q
    Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Lipoic acid prevents the intestinal epithelial monolayer damage under heat stress conditions: model experiments in Caco-2 cells.
    Varasteh S; Fink-Gremmels J; Garssen J; Braber S
    Eur J Nutr; 2018 Jun; 57(4):1577-1589. PubMed ID: 28349254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
    Langford RM; Mares J; Novotna A; Vachova M; Novakova I; Notcutt W; Ratcliffe S
    J Neurol; 2013 Apr; 260(4):984-97. PubMed ID: 23180178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha lipoic acid and superoxide dismutase in the treatment of chronic low back pain.
    Battisti E; Albanese A; Guerra L; Argnani L; Giordano N
    Eur J Phys Rehabil Med; 2013 Oct; 49(5):659-64. PubMed ID: 23860422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of alpha-lipoic acid by complex formation with octenylsuccinylated high-amylose starch.
    Li YX; Kim YJ; Reddy CK; Lee SJ; Lim ST
    Carbohydr Polym; 2019 Sep; 219():39-45. PubMed ID: 31151539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-lipoic acid downregulates TRPV1 receptor via NF-κB and attenuates neuropathic pain in rats with diabetes.
    Zhang BY; Zhang YL; Sun Q; Zhang PA; Wang XX; Xu GY; Hu J; Zhang HH
    CNS Neurosci Ther; 2020 Jul; 26(7):762-772. PubMed ID: 32175676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain.
    Khan N; Kuo A; Brockman DA; Cooper MA; Smith MT
    Inflammopharmacology; 2018 Feb; 26(1):77-86. PubMed ID: 28965161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Nutraceutical Compositions Containing Rhizoma Gastrodiae or Lipoic Acid in an In Vitro Induced Neuropathic Pain Model.
    Ferrari S; Mulè S; Galla R; Brovero A; Genovese G; Molinari C; Uberti F
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions.
    Duffy SS; Lees JG; Perera CJ; Moalem-Taylor G
    Med Chem; 2018 Feb; 14(2):106-119. PubMed ID: 28875858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study.
    Rossi S; Mataluni G; Codecà C; Fiore S; Buttari F; Musella A; Castelli M; Bernardi G; Centonze D
    Eur J Neurol; 2009 Mar; 16(3):360-6. PubMed ID: 19364364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination pharmacotherapy for the treatment of neuropathic pain in adults.
    Chaparro LE; Wiffen PJ; Moore RA; Gilron I
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD008943. PubMed ID: 22786518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.
    Gupta SV; Gupta D; Sun J; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2011 Dec; 8(6):2358-67. PubMed ID: 21905667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.